The Light Microscopy Core Facility (LMCF) at Duke serves as the Light Microscopy Shared Resource for the Duke Cancer Institute (DCI). The facility offers affordable and efficient access to more than $6 million of confocal and conventional fluorescence microscopes and image analysis resources to all members of the University and the Medical Center. Dedicated staff provides training and full technical support for all the instruments; DCI members receive priority for training. Trained users can access the equipment 24 hours a day. The LMCF is funded by the DCI (including the CCSG), the Duke University School of Medicine, the Duke University Office of the Provost, the National Institutes of Health, and the North Carolina Biotechnology Center, in addition to user fees. The LMCF provides access to confocals (eight), live cell fluorescence microscopes, spinning disk, multiphoton, TIRF and more to allow fluorescence imaging of samples ranging from fixed immunofluorescence slides and live cell tissue culture models, to model organisms and intravital imaging of mice. Essentially all standard optical sectioning and microscopy methods are present - confocal, resonant scanning confocal, spinning disk, live cell imaging with several modalities, long-term incubated time-lapse, multiphoton including with scale-cleared samples allowing imaging up to 8 mm into the sample, photoactivation/photoconversion and photokinetic (FRAP, FLIP) capabilities, time-correlated single-photon counting fluorescence lifetime imaging and a broad range of analysis capabilities are available, with training and assistance, to all users. The shared resource's three full-time PhD-level staff members provide assistance with all aspects of imaging, including processing and quantitative analysis of images. From 2009 through 2013, LMCF was used by over 1,200 people (over 2,200 trainings) from over 360 labs for over 106,000 hours of imaging over 41,000 sessions. In 2012 LMCF was used 10,611 times by 223 labs for 28,622 hours of imaging and analysis. In 2012, 96 of the 223 labs (43%) were from the DCI; of those, 82 (85%) had peer-reviewed funding and 14 (15%) did not. 226 publications from DCI members resulted from LMCF usage during the funding period. LMCF's DCI users represent all nine CCSG-recognized Research Programs. Booking is done on a first-come, first-served basis with some limits to promote efficient use. The significant number of machines in the facility provides good capacity, availability of the machines is good, and bottlenecks are generally few and temporary. In recognition of the CCSG-contribution, DCI members are prioritized for training and assistance. The facility's ongoing priority is continued support of the users and systems for continued productivity, with acquisition and implementation of new technologies if they prove valuable.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-44
Application #
9404296
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-01-01
Budget End
2018-12-31
Support Year
44
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Gearhart-Serna, Larisa M; Jayasundara, Nishad; Tacam Jr, Moises et al. (2018) Assessing Cancer Risk Associated with Aquatic Polycyclic Aromatic Hydrocarbon Pollution Reveals Dietary Routes of Exposure and Vulnerable Populations. J Environ Public Health 2018:5610462
Bakthavatsalam, Subha; Sleeper, Mark L; Dharani, Azim et al. (2018) Leveraging ?-Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer Cells. Angew Chem Int Ed Engl 57:12780-12784
Dai, Ziwei; Mentch, Samantha J; Gao, Xia et al. (2018) Methionine metabolism influences genomic architecture and gene expression through H3K4me3 peak width. Nat Commun 9:1955
Powell Gray, Bethany; Kelly, Linsley; Ahrens, Douglas P et al. (2018) Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer. Proc Natl Acad Sci U S A 115:4761-4766
Abdi, Khadar; Lai, Chun-Hsiang; Paez-Gonzalez, Patricia et al. (2018) Uncovering inherent cellular plasticity of multiciliated ependyma leading to ventricular wall transformation and hydrocephalus. Nat Commun 9:1655
Hudson, Kathryn E; Rizzieri, David; Thomas, Samantha M et al. (2018) Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study. Br J Haematol :
Fayanju, Oluwadamilola M; Park, Ko Un; Lucci, Anthony (2018) Molecular Genomic Testing for Breast Cancer: Utility for Surgeons. Ann Surg Oncol 25:512-519
Porter, Laura S; Fish, Laura; Steinhauser, Karen (2018) Themes Addressed by Couples With Advanced Cancer During a Communication Skills Training Intervention. J Pain Symptom Manage 56:252-258
Káradóttir, Ragnhildur T; Kuo, Chay T (2018) Neuronal Activity-Dependent Control of Postnatal Neurogenesis and Gliogenesis. Annu Rev Neurosci 41:139-161
Han, Peng; Liu, Hongliang; Shi, Qiong et al. (2018) Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck. Mol Carcinog 57:784-793

Showing the most recent 10 out of 513 publications